Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP114163.RAk09O52jBPdeGsc0CG_HGrVgB1EXUdbsDMkEgJ5IbNJE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP114163.RAk09O52jBPdeGsc0CG_HGrVgB1EXUdbsDMkEgJ5IbNJE130_assertion type Assertion NP114163.RAk09O52jBPdeGsc0CG_HGrVgB1EXUdbsDMkEgJ5IbNJE130_head.
- NP114163.RAk09O52jBPdeGsc0CG_HGrVgB1EXUdbsDMkEgJ5IbNJE130_assertion description "[For GSTM1 genotypes, the overall values (controls plus patients with thyroid cancer; no.= 335) indicated that the frequency of the null genotype was 49.85%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP114163.RAk09O52jBPdeGsc0CG_HGrVgB1EXUdbsDMkEgJ5IbNJE130_provenance.
- NP114163.RAk09O52jBPdeGsc0CG_HGrVgB1EXUdbsDMkEgJ5IbNJE130_assertion evidence source_evidence_literature NP114163.RAk09O52jBPdeGsc0CG_HGrVgB1EXUdbsDMkEgJ5IbNJE130_provenance.
- NP114163.RAk09O52jBPdeGsc0CG_HGrVgB1EXUdbsDMkEgJ5IbNJE130_assertion SIO_000772 19169061 NP114163.RAk09O52jBPdeGsc0CG_HGrVgB1EXUdbsDMkEgJ5IbNJE130_provenance.
- NP114163.RAk09O52jBPdeGsc0CG_HGrVgB1EXUdbsDMkEgJ5IbNJE130_assertion wasDerivedFrom lhgdn-20090331 NP114163.RAk09O52jBPdeGsc0CG_HGrVgB1EXUdbsDMkEgJ5IbNJE130_provenance.
- NP114163.RAk09O52jBPdeGsc0CG_HGrVgB1EXUdbsDMkEgJ5IbNJE130_assertion wasGeneratedBy ECO_0000203 NP114163.RAk09O52jBPdeGsc0CG_HGrVgB1EXUdbsDMkEgJ5IbNJE130_provenance.